|
Epilepsies, Partial
|
0.010 |
Biomarker
|
disease |
BEFREE |
We reviewed the video-EEG recordings of 1,006 patients with drug-resistant focal epilepsy included in the REPO<sub>2</sub>MSE study to identify those with ≥1 GCS and pulse oximetry (SpO<sub>2</sub>) measurement.
|
30568004 |
2019 |
|
Generalized convulsive epilepsy
|
0.010 |
Biomarker
|
disease |
BEFREE |
We reviewed the video-EEG recordings of 1,006 patients with drug-resistant focal epilepsy included in the REPO<sub>2</sub>MSE study to identify those with ≥1 GCS and pulse oximetry (SpO<sub>2</sub>) measurement.
|
30568004 |
2019 |
|
Bradycardia-tachycardia syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
Comparison occurred in terms of signal similarity (evaluated by the correlation coefficient ρ, and the mean signal error MSE) and clinical features (including FHR baseline and variability; number, amplitude and duration of tachycardia, bradycardia, acceleration and deceleration episodes; number of early, variable, late and prolonged decelerations; and UC number, amplitude, duration and period).
|
29428065 |
2018 |
|
Acute myelomonocytic leukemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The following samples were positive for MSE protein and Northern mRNA expression: 20/24 monocytic, 4/32 myeloid, and 1/20 erythroid-megakaryocytic leukemia cell lines, but none of the 112 lymphoid leukemia or lymphoma cell lines; of the normal purified cell populations only the monocytes were positive whereas, T, B cells, and granulocytes were negative; of primary acute (myelo) monocytic leukemia cells (CD14-positive, FAB M4/M5 morphology) 14/20 were Northern mRNA and 11/14 IEF protein positive.
|
8090031 |
1994 |
|
Lymphoma
|
0.010 |
AlteredExpression
|
group |
BEFREE |
The following samples were positive for MSE protein and Northern mRNA expression: 20/24 monocytic, 4/32 myeloid, and 1/20 erythroid-megakaryocytic leukemia cell lines, but none of the 112 lymphoid leukemia or lymphoma cell lines; of the normal purified cell populations only the monocytes were positive whereas, T, B cells, and granulocytes were negative; of primary acute (myelo) monocytic leukemia cells (CD14-positive, FAB M4/M5 morphology) 14/20 were Northern mRNA and 11/14 IEF protein positive.
|
8090031 |
1994 |
|
Adult Lymphoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The following samples were positive for MSE protein and Northern mRNA expression: 20/24 monocytic, 4/32 myeloid, and 1/20 erythroid-megakaryocytic leukemia cell lines, but none of the 112 lymphoid leukemia or lymphoma cell lines; of the normal purified cell populations only the monocytes were positive whereas, T, B cells, and granulocytes were negative; of primary acute (myelo) monocytic leukemia cells (CD14-positive, FAB M4/M5 morphology) 14/20 were Northern mRNA and 11/14 IEF protein positive.
|
8090031 |
1994 |
|
Childhood Lymphoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The following samples were positive for MSE protein and Northern mRNA expression: 20/24 monocytic, 4/32 myeloid, and 1/20 erythroid-megakaryocytic leukemia cell lines, but none of the 112 lymphoid leukemia or lymphoma cell lines; of the normal purified cell populations only the monocytes were positive whereas, T, B cells, and granulocytes were negative; of primary acute (myelo) monocytic leukemia cells (CD14-positive, FAB M4/M5 morphology) 14/20 were Northern mRNA and 11/14 IEF protein positive.
|
8090031 |
1994 |